On Wednesday, Shares of Twitter, Inc. (NYSE:TWTR), lost -0.43% to $37.26.
According to Marketwatch, Twitter has suffered the biggest seven-day percentage loss, on a rolling basis, in its 18-month history. The stock fell 0.4% on Wednesday to close at the lowest level since Jan. 30. It has lost 27.9% since the social network giant stated first-quarter results on April 28. The company has lost $9.42 billion in market capitalization during that time. The stock sits 49% below its all-time closing high of $73.31, reached on Dec. 26, 2013, but is still 43% above its $26 initial public price. The stock debuted for trade on Nov. 7, 2013.
Twitter, Inc. operates as a global platform for public self-expression and conversation in real time. It offers various products and services for users, counting Twitter that allows users to create, distribute, and discover content; and Vine and video, a mobile application that enables users to create and distribute short looping videos.
Shares of Facebook, Inc. (NASDAQ:FB), gained 0.70% to $78.10, during its last trading session.
According to Reuters, The leader of Facebook Inc’s fast-growing Seattle office left the company last month, a spokeswoman for the online social network told Reuters on Wednesday, a crucial personnel change at Facebook’s largest engineering office outside of its Silicon Valley headquarters.
Engineering manager Paul Carduner, who took over leadership of the Seattle office about six months ago, was in charge of more than 600 people.
In February he declared a lease on space in a new building in Seattle with room for more than 2,000 Facebook employees. The office is expecting to move there in January 2016.
Facebook did not publicize his departure and it has not been stated formerly. No replacement has been named, a source at the company told Reuters, and senior staff in Seattle are sharing Carduner’s duties.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
At the end of Wednesday’s trade, Shares of General Electric Company (NYSE:GE), lost -0.41% to $26.81.
General Electric Company, gathered industry thought leaders and influencers from Qualcomm, City of San Diego, City of Jacksonville to share insights on how intelligent LED lighting is transforming cities, buildings and homes. The marriage of lighting and big data provides new ways to drive unprecedented efficiency, utility and experiences that will change the way we navigate our hometown, the way we shop at the grocery store and the way we live everyday life.
The cities of San Diego and Jacksonville are working with GE Lighting on trials of software-enabled LED lighting solution. David Graham, Deputy Chief Operating Officer, City of San Diego, and Jim Robinson, Director of Public Works, City of Jacksonville, shared how their cities plan to use this pilot program to analyze data trends to assist citizens and visitors find parking in their cities.
In partnership with Qualcomm, this same technology concept is being applied to buildings – specifically looking to transform the retail experience. Using visible light communication (VLC), this high accuracy solution can locate a shopper up to 5 cm and provide a shopper’s orientation and elevation date, allowing retailers to give shoppers relevant product promotions or educational content. For example, this technology could assist someone find gluten-free products at the grocery.
General Electric Company (GE) operates as an infrastructure and financial services company worldwide. The company’s Power and Water segment offers gas, steam and aeroderivative turbines, nuclear reactors, generators, combined cycle systems, controls, and related services; wind turbines; and water treatment services and equipment.
Finally, Pfizer Inc. (NYSE:PFE), ended its last trade with -1.12% loss, and closed at $33.46.
Pfizer, declared two planned appointments in the leadership of the Worldwide Research and Development organization effective right away. Michael D. Ehlers, M.D., Ph.D., has been selected as Group Senior Vice President and Head of BioTherapeutics Research & Development and Site Head for Pfizer’s Cambridge and Boston, Massachusetts locations. Dr. Ehlers will report directly to Mikael Dolsten, M.D., Ph.D., President of Worldwide Research & Development. In addition, John Lin, M.D., Ph.D., has been selected as Senior Vice President and Chief Scientific Officer of Rinat. Dr. Lin will report directly to Robert T. Abraham, Ph.D., Group Senior Vice President for Oncology-Rinat Research & Development.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
